Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.51 USD | -2.33% | -7.38% | -64.85% |
Business Summary
Number of employees: 25
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Eyecare & Wound Care
75.9
%
| 10 | 71.1 % | 11 | 75.9 % | +9.13% |
Skincare
24.1
%
| 4 | 28.9 % | 4 | 24.1 % | -14.72% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 14 | 100.0 % | 15 | 100.0 % | +2.24% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Justin Hall
CEO | Chief Executive Officer | 46 | 31/01/13 |
Tommy Law
DFI | Director of Finance/CFO | 38 | 30/11/19 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Paul Freiman
CHM | Chairman | 89 | 30/04/02 |
Yen You Zheng
BRD | Director/Board Member | 67 | 10/09/19 |
Bob Wu
BRD | Director/Board Member | 49 | 25/01/16 |
Justin Hall
CEO | Chief Executive Officer | 46 | 31/01/13 |
Julie Garlikov
BRD | Director/Board Member | 53 | 26/01/22 |
Swan Sit
BRD | Director/Board Member | 46 | 16/12/19 |
Yong Xiang Zheng
BRD | Director/Board Member | 54 | 26/01/22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 1,000 | 0 | 0 | 99.97 % |
Stock B | 1 | 1,151,715 | 1,151,399 ( 99.97 %) | 0 | |
Stock C | 0 | 1,000 | 0 | 0 |
Company contact information
NovaBay Pharmaceuticals, Inc.
2000 Powell Street Suite 1150
94608-1866, Emeryville
+510 899 8800
http://www.novabay.comSector
Sales per Business
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-64.85% | 2.89M | |
+40.80% | 53.67B | |
+35.79% | 38.86B | |
-8.05% | 38.76B | |
-8.98% | 27.27B | |
+10.69% | 25.91B | |
-16.21% | 20.29B | |
+31.00% | 12.78B | |
+28.51% | 12.18B | |
-1.67% | 11.96B |
- Stock Market
- Equities
- NBY Stock
- Company NovaBay Pharmaceuticals, Inc.